The metabolic pathway analysis (Fig
Newer agents such as tirzepatide (a dual GIP/GLP-1 receptor agonist) may offer different tolerability profiles, though gastrointestinal effects remain common and availability on the NHS may be limited pending NICE appraisal and local commissioning decisions
52 Limited research on MAFLDs impact on infectious diseases shows higher infection rates, longer/complicated courses, and increased fatality from infections like Helicobacter pylori , Clostridium difficile , COVID-19, bacterial pneumonia, periodontitis, urinary tract infection, and HIV
Common Questions What should I do if I miss a dose of semaglutide
In contrast, people whose diabetes is managed by diet alone or with non-insulin medicines (tablets or injectable medicines such as GLP-1 receptor agonists) may be eligible if their diabetes is stable and they have no related complications